Paul Ehrlich’s vision of a rational targeted strategy against invading microbes or malignant cells has been a driving research throughout the past century, bringing a scientific and therapeutic ...

Over the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for use in patients. Investigators recently ...